The new Labcor-Santiago pericardial bioprosthesis

Area of Science:

• Cardiovascular Surgery
• Biomaterials Engineering
• Medical Device Design

Background:

• Traditional pericardial valves face challenges with mechanical stress and abrasion wear.
• The Labcor-Santiago valve was developed to address these limitations while maintaining hemodynamic function.

Purpose of the Study:

• To evaluate the safety and performance of the novel Labcor-Santiago pericardial valve.
• To assess the hemodynamic characteristics and early clinical outcomes of this new valve design.

Main Methods:

• A prospective study involving 40 patients (46 valves implanted) in aortic and mitral positions.
• Utilized Echo-Doppler assessments to evaluate hemodynamic parameters like effective orifice area and gradients.
• Monitored clinical outcomes including mortality, thromboembolic events, and functional class.

Main Results:

• Hospital mortality was 12.5%. One thromboembolic event occurred in patients not receiving anticoagulation.
• Favorable hemodynamic results were observed, with effective orifice areas of 1 cm² (aortic 19mm) and 2 cm² (mitral 27mm).
• Low mean systolic (aortic) and diastolic (mitral) gradients were recorded, indicating good flow dynamics.

Conclusions:

• The Labcor-Santiago pericardial valve demonstrates promising early clinical and hemodynamic performance.
• The design innovations aim to enhance mechanical durability and reduce wear, potentially improving long-term outcomes.
• The valve's characteristics facilitate comfortable implantation, especially in patients with small aortic annuli.